Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lens

CONCLUSIONS: Our call to action is to expand access to comprehensive genomic testing, foster a learning health care system, enable fast and equitable access to cost-effective treatments, and ultimately improve health outcomes.PMID:38630538 | DOI:10.1093/oncolo/oyae060

Source: The Oncologist - April 17, 2024 Category: Cancer & Oncology Authors: Priscila Radu Gayathri Kumar Amanda Cole Aikaterini Fameli Mark Guthrie Lieven Annemans Jan Geissler Antoine Italiano Brian O'Rourke Entela Xoxi Lotte Steuten Source Type: research